• Journal of Microbiology and Biotechnology
• /
• 제23권11호
• /
• pp.1500-1508
• /
• 2013

Ebosin, a novel exopolysaccharide produced by Streptomyces sp. 139, has obvious antirheumatic arthritis activity in vivo, and its biosynthesis gene cluster (ste), consisting of 27 open reading frames, has been identified. This paper reports our study of the gene functionality of ste8, the predicted protein product of which is homologous to some bacterial chain length determinant Wzz proteins. For characterization of Ste8, ste8 was cloned and expressed in the mutant strain E. coli 086:H2 (${\Delta}wzz$). The functional complementation of wzz by ste8 was demonstrated by the restoration of wild-type lipopolysaccharide biosynthesis and increased levels of serum resistance of E. coli 086:H2 (${\Delta}wzz$) (pET30a-ste8). To examine the function of ste8 in ebosin biosynthesis, the gene was knocked out with a double crossover via homologous recombination. The molecular weight of the ebosin derivative EPS-8m produced by the mutant Streptomyces sp. 139 ($ste8^-$) was much lower than that of ebosin, and the binding activity of EPS-8m for IL-1R decreased significantly compared with ebosin. These results demonstrate that ste8 encodes a chain length determinant (Wzz) that functions in ebosin biosynthesis.

• 전기화학회지
• /
• 제19권1호
• /
• pp.21-27
• /
• 2016

바나듐 레독스 흐름 전지는 황산 바탕용액 내 바나듐 이온을 함유하는 전해질을 활용하여 충전과 방전을 번갈아 운전하는 에너지 저장 장치 중 하나이다. 양극액엔 $V^{5+}$와 $V^{4+}$가 음극액엔 $V^{2+}$와 $V^{3+}$가 충전 또는 방전 모드에 따라 주로 존재하게 된다. 두 종류의 바나듐 용액이 혼액되는 것을 방지하기 위해 주로 수소이온교환막을 활용하여 전체 셀을 완성하게 된다. $V^{5+}$의 높은 산화력으로 현재 듀퐁사의 Nafion 117이 유력하나 바나듐 이온의 높은 크로스오버라는 단점을 극복해야 한다. 본 연구에서는 상기 단점을 극복할 뿐만 아니라 고가의 Nafion계 막의 가격을 저감하고 화학적 안정성을 지속적으로 유지하기 위해 다공성 폴리에틸렌 필름에 나피온 고분자를 함침하여 바나듐 레독스 흐름 전지용 복합막을 제조하였으며, 상용막인 Nafion 117과 성능을 비교 분석하였다. 복합막의 두께가 두꺼워질수록 함수율과 이온전도도가 증가 하였으나 Nafion 117에 비해 다소 낮은 성능을 확인하였으며, 바나듐 이온의 투과성은 현저히 줄어드는 것을 확인할 수 있었다. 충 방전 실험 결과, $190{\mu}m$ 두께의 나피온 복합막이 가장 좋은 성능을 보였으며, Nafion 117과 비교하여 전압효율은 낮아졌지만, 충 방전 효율이 높아져 전체적인 에너지 효율은 비슷하게 측정되었다. 또한 6.4% 중량비에 해당하는 지지체만큼의 과불소화 술폰산 고분자의 중량이 감소함에 따라 비용을 절감할 수 있었으며, 성능면에서는 바나듐 이온의 투과도를 낮추어 자가 방전 속도를 저하시키면서 충 방전 용량의 감소가 느려지는 것을 알 수 있었다.

• 전기화학회지
• /
• 제11권4호
• /
• pp.256-261
• /
• 2008

본 연구에서는 나피온 막을 통한 메탄올 투과도를 감소시키기 위하여 양전하를 띠는 polyaniline(PANi)와 음전하를 갖는 sulfonated Poly(ether sulfone)(SPES)으로부터 다층 자기조립 박막법으로 나피온 막의 표면을 개질하였다. PANi과 SPES는 열적 화학적으로 안정하며 매우 강직한 특성을 띄고 있어, 나피온 막 표면에 다층 자기조립 박막 형성시 메탄올 투과도 감소 및 치수 안정성의 향상을 기대할 수 있다. 자외선-가시광선 흡광분석에 의하여 PANi와 SPES의 다층박막의 형성이 균일하게 이루어짐을 확인 하였다. TEM 분석을 통하여 다층 자기조립 박막의 bilayer당 두께가 약 10 nm 정도임을 확인 하였다. 개질된 나피온 막은 순수한 나피온 막에 비하여 15%의 이온전도도 감소가 일어났지만 67%의 높은 메탄올 투과도 감소를 나타내어 2.5배 높은 선택도를 보였다. 5 M 메탄올을 연료로 사용한 연료전지 성능시험에서 개질된 나피온 막은 순수한 나피온 막에 비해 최대 전력 밀도가 $30^{\circ}C$에서는 2.4배 증가, $60^{\circ}C$에서는 1.4배 향상을 나타내었다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제30권5호
• /
• pp.653-659
• /
• 2017

Objective: This trial was performed to examine the effects of ruminally degradable starch (RDS) levels in total mixed ration (TMR) with low corn-based starch on the milk production, whole-tract nutrient digestibility and nitrogen balance in dairy cows. Methods: Eight multiparous Holstein cows (body weight [BW]: $717{\pm}63kg$; days in milk [DIM]: $169{\pm}29$) were assigned to a crossover design with two dietary treatments: a diet containing 62.3% ruminally degradable starch (% of total starch, low RDS) or 72.1% ruminally degradable starch (% of total starch, high RDS). Changes to the ruminally degradable levels were conducted by using either finely ground corn or steam-flaked corn as the starch component. Results: The results showed that dry matter intake, milk yield and composition in dairy cows were not affected by dietary treatments. The concentration of milk urea nitrogen was lower for cows fed high RDS TMR than low RDS TMR. The whole-tract apparent digestibility of neutral detergent fiber, acid detergent fiber and crude protein decreased, and that of starch increased for cows fed high RDS TMR over those fed low RDS TMR, with no dietary effect on the whole-tract apparent digestibility of dry matter and organic matter. The proportion of urinary N excretion in N intake was lower and that of fecal N excretion in N intake was higher for cows fed high RDS TMR than those fed low RDS TMR. The N secretion in milk and the retention of N were not influenced by the dietary treatments. Total purine derivative was similar in cows fed high RDS TMR and low RDS TMR. Consequently, estimated microbial N flow to the duodenum was similar in cows fed high RDS TMR and low RDS TMR. Conclusion: Results of this study show that ruminally degradable starch levels can influence whole-tract nutrient digestibility and nitrogen balance in dairy cows fed low corn-based starch diets, with no influence on performance.

• Asian-Australasian Journal of Animal Sciences
• /
• 제21권9호
• /
• pp.1252-1261
• /
• 2008

Twenty-four yearling Boer$\times$Spanish goats were used in a crossover design experiment to determine effects of tethering on forage selection, intake and digestibility, grazing behavior and energy expenditure (EE) with forage high in nutritive value and low to moderate in mass. Objectives were to determine if tethered goats could be used as a model for study of unrestrained animals and to characterize tethering as a production practice. Four 0.72-ha pastures of wheat (Triticum aestivum) and berseem clover (Trifolium alexandrium) were grazed in December and January. Each pasture hosted six animals, three with free movement and three attached to a 4.11-m tether for access to a circular area of $53.1m^2$. Tethering areas were moved each day. One animal of each treatment and pasture was used to determine forage selection, fecal output or grazing behavior and EE; therefore, there were eight observations per treatment. Mass of forage DM before grazing in Tethered areas averaged 1,280 and 1,130 kg/ha in periods 1 and 2, respectively. The CP concentration in ingesta was greater ((p<0.05) 239 and 209 g/kg; SE = 8.0) and the NDF level was lower (p<0.05) for Free vs. Tethered animals (503 and 538 g/kg; SE = 12.0); in vitro true DM digestion was similar between treatments (0.808 and 0.807 for Free and Tethered, respectively; SE = 0.0096). Intakes of DM (1,013 and 968 g/d; SE = 78.6), NDF (511 and 521 g/d; SE = 39.9) and ME (10.9 and 10.7 MJ/d; SE = 0.90) were similar between treatments, but CP intake was greater (p<0.05) for Free vs. Tethered animals (241 and 203 g/d; SE = 17.2). There were small treatment differences in in vivo apparent digestibility of OM ((p<0.05) 0.780 and 0.814; SE = 0.0049), CP ((p<0.05) 0.800 and 0.817; SE = 0.0067) and NDF ((p<0.09) 0.777 and 0.760 for Free and Tethered, respectively; SE = 0.0078). There were no treatment effects on time spent ruminating or grazing (346 and 347 min/d for Free and Tethered, respectively; SE = 42.5), but EE was considerably greater (p<0.05) for Free vs. Tethered animals (571 and 489 kJ/kg $BW^{0.75}$; SE = 8.9). In conclusion, with forage of high nutritive value and low to moderate in mass, tethering can offer a production advantage over free grazing of less energy used for activity despite similar grazing time. With forage removal considerably less than that available for grazing, effects of tethering on chemical composition of selected forage were small and less than needed to markedly affect digestion. Tethering may offer a means of studying some aspects of grazing by ruminants, but would not seem suitable for energy metabolism.

• Asian-Australasian Journal of Animal Sciences
• /
• 제18권7호
• /
• pp.973-979
• /
• 2005

The present study was planned to examine the effect of different feeding regimens on milk urea concentration and milk protein concentration. The objectives are to describe the diurnal variations of milk urea (MU) concentration and to predict plasma urea (PU) concentration from MU concentration. Six lactating Murrah buffaloes were distributed in two groups and were fed two different diets in a crossover design. The diets consisted of leguminous crops as diet 1 (berseem (Trifolium alexandrinum)+concentrate mixture 1+wheat straw)) and non-leguminous crops as diet 2 (oats (Avana sativa)+concentrate mixture 2+wheat straw). All the diets were isocaloric and isonitrogenous. Each diet was fed to the animals for a period of 28 days, followed by a 10 day gap to obviate the carry over effect of the previous diet and then a switch over to the other diet. Digestibility trials were conducted on the last 7 days of each feeding period. Milk samples were collected on day 3, 7, 10, 14, 17, 21, 24 and 28 of the feeding period and blood samples were collected on the same day at morning within 30 minutes after morning milking. The average milk urea (MU) values (mg/dl) differed significantly (p<0.01) and were 44.83${\pm}$0.62 and 42.53${\pm}$0.73, respectively, for diets 1 and 2. Milk urea concentrations (mg/dl) also varied (p 0.01) among the days of feeding period, but were stabilized after 10th day of feeding period. In contrast, diets and days of feeding period had no significant effect on percent milk protein. Plasma urea concentration showed a significant (p<0.01) positive correlation (r = 0.93) with MU concentration. To predict the PU from MU the following equation was developed 'PU = 10.67${\pm}$0.76${\times}$MU (mg/dl) with $R^2$ = 0.87'. A clear diurnal variation of MU was found with lowered morning value (42.04${\pm}$0.68 mg/dl) than the evening value (45.32${\pm}$0.66 mg/dl). Present findings suggested that MU or PU concentration could be used as an indicator to monitor the feeding strategy. Plasma urea can be predicted from MU, whenever interpretation of milk urea data required consideration of diurnal variation.

• 멤브레인
• /
• 제30권5호
• /
• pp.307-318
• /
• 2020

기존의 바나듐 레독스 흐름전지(vanadium redox flow battery, VRFB)에서 사용하고 있는 과불소계이오노머인 나피온(Nafion)은 전해질에 존재하는 바나듐 이온의 투과도가 높아, 바나듐 이온이 분리막을 투과하여 반대쪽 전해질로 교차 이동하는 문제를 갖고 있다. VRFB에서 바나듐 이온의 투과는 서로 다른 산화수를 갖는 바나듐 이온이 부반응을 일으켜 충전, 방전 용량의 감소를 야기하고, 장기적인 성능 감소를 일으키는 원인이 된다. 이러한 문제를 해결하기 위해 본 연구에서는 SiO₂에 3-aminopropyl group이 도입된 나노입자(fS)를 Nafion에 분산시켜 바나듐 이온의 투과를 감소시키고, VRFB의 장기적인 성능의 향상을 도모하고자 하였다. SiO₂에 붙어 있는 아민기(-NH₂)가 Nafion의 술폰산 음이온(SO₃^-)과 이온결합을 형성함과 동시에, 암모늄 양이온(-NH₃⁺)의 양전하가 바나듐 이온에 대해 Gibbs-Donnan 효과를 나타내어 낼 것이라고 기대하였다. fS를 섞은 Nafion 용액의 pH와 Nafion-fS 막의 IEC 측정을 통해 암모늄 양이온과 술폰산 음이온의 이온결합이 존재하는 것을 확인하였고, fS의 양이 많아질수록 바나듐 이온의 투과도가 감소하는 것을 확인하였다. VRFB 단위 전지에 제조한 복합막을 도입하였을 때, 150 mA/㎠의 전류밀도에서 충방전 사이클을 200회 반복 진행하여도 방전용량을 최대 80%까지 유지할 수 있었다.

• 한국임상수의학회지
• /
• 제19권2호
• /
• pp.186-190
• /
• 2002

아토피성 피부염은 면역계재성 피부질환으로 소양증이 주요 증상이며 이의 치료가 필수적이다. 따라서 개에서 제2세대 항히스타민제의 임상적용을 위해 피부에 히스타민에 의해 유발된 팽진과 발적에 대한 loratadine, cetirizine과 terfenadine의억제 효과를 비교하였다. 3종의 항히스타민제는 대조군에 비해 매우 유의하게 발적반응을 억제하였으며(p<0.01) cetirizine이 다른 제제에 비해 높은 억제효과를 보였다. 3종의 항히스타민제는 팽진 반응을 억제하는 효과를 보였으며 loratadine의 억제효과가 일정하며 지속적이었다. 따라서 제 2세대 항히스타민제인 loratadine과 cetirizine은 개에서 아토피성 피부염의 소양증 치료에 적용할 수 있는 항히스타민제로 사료된다. 특히 스테로이드제제를 대체할 수 있는 치료효과를 보일 것으로 판단된다.

• Biomolecules & Therapeutics
• /
• 제9권4호
• /
• pp.291-297
• /
• 2001

The bioequivalence of two triflusal products was evaluated with 20 healthy volunteers following single oral dose according to the guidelines of Korea Food and Drug Administration (KFDA). Trisa $l^{R}$ capsule (Whanin Pharm. Corp., Korea) and Disgre $n^{R}$ capsule (Myung-In Pharm. Corp., Korea) were used as test product and reference product, respectively. Both products contain 300 mg of trifusal. One capsule of test product or reference product was orally administered to the volunteers, respectively, by randomized two period crossover study (2$\times$2 Latin square method). Blood samples were taken at predetermined time intervals for 4 hours and the determination of trifusal was accomplished using semi-microbore HPLC equipped with automated column switching system. The analytical method with HPLC was validated according to the Bioanalytic Method Validation guideline by F7A prior to determining the plasma samples. The pharmacokinetic parameters (AU $C_{0-4h}$ $C_{max}$ and $T_{max}$) were calculated and ANOVA test was utilized for statistical analysis of parameters. As a result of the assay validation, the limit of quantification of trifusal in human plasma by current assay procedure was 50 ng/ml using 500 $\mu$l of plasma. The accuracy of the assay was from 97.76% to 116.51% while the intra-day and inter-day coefficient of variation of the same concentration range was less than 15%. Average drug concentration at the designated time intervals and pharmacokinetic parameters calculated were not significantly different between two products (p>0.05). The difference of mean AU $C_{olongrightarrow4hr}$, $C_{max}$, and $T_{max}$ between the two products (2.92, 4.39, and -2.44%, respectively) were less than 20%. The power (1-$\beta$) and treatment difference ($\Delta$) for AU $C_{olongrightarrow4hr}$ and $C_{max}$ were more than 0.8 and less than 0.2, respectively. Although the power for $T_{max}$ was under 0.8, $T_{max}$ of the two products was not significantly different from each other (p>0.05). These results satisfied the criteria of KFDA guideline for bioequivalence, indicating the two products of triflusal were bioequivalent.quivalent.ent.ent.

• Journal of Pharmaceutical Investigation
• /
• 제30권1호
• /
• pp.55-59
• /
• 2000

Bioequivalence of two cisapride tablets, test drug ($Cisple^{\circledR}$ tablet: Hanmi Pharm Co., Ltd.) and reference drug ($Prepulsid^{\circledR}$ tablet: Janssen Pharm. Co., Ltd.), was evaluated according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty two healthy male volunteers were divided randomly into two groups and administered the drug orally at the dose of 10 mg as cisapride in a $2{\times}2$ crossover study. There was a week washout period between administrations. Blood samples were taken at predetermined time intervals for 36 hr and the plasma concentration of cisapride was determined by a HPLC method. $AUC_{0-36hr}$ (area under the plasma concentration-time curve from time zero to 36 hr), $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were estimated from the plasma drug concentration-time data. Analysis of variance (ANOVA) revealed no difference in $AUC_{0-36hr},\;C_{max}\;and\;T_{max}$ between two products. The apparent differences of these parameters between two products were less than 20% (i.e., 5.38, 6.17 and 0.00% for $AUC_{0-36hr},\;C_{max}\;and\;T_{max},$ respectively). The powers $(1-\beta)$ for $AUC_{0-36hr},\;C_{max}\;and\;T_{max}$ were over 0.9. Minimal detectable differences $(\Delta)$ at ${\alpha}=0.05,\;1-{\beta}=0.8$ were less than 20% (i.e. 17.67, 14.84 and 19.72% for $AUC_{0-36hr},\;C_{max}\;and\;T_{max},$ respectively). The 90% confidence intervals $(\delta)$ for these parameters were also within ${\pm}20%$ $(i.e.\;-4.97\;{\le}{\delta}{\le}\;15.73,\;-2.53{\le}{\delta}{\le}\;14.86\;and\;-11.55{\le}{\delta}{\le}\;11.55$ for $AUC_{0-36hr},\;C_{max}\;and\;T_{max},$ respectively). These results satisfied the criteria of KFDA guidelines for bioequivalence, indicating the two tablets of cisapride were bioequivalent.